Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 139,164 shares at $38.42 ($5.3M) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $5.3M RPRX by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.42 | 3,750 | $144K | 2.7% |
| 2 | $38.42 | 65,832 | $2.5M | 47.3% |
| 3 | $38.42 | 3,750 | $144K | 2.7% |
| 4 | $38.42 | 65,832 | $2.5M | 47.3% |
| Total | $38.42 avg | 139,164 | $5.3M | 100% |
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |